Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
35
|
pubmed:dateCreated |
1986-10-15
|
pubmed:abstractText |
Fifteen patients with confirmed psoriatic arthritis were treated with recombinant interferon-gamma (IFN-gamma) between October 1985 and February 1986. In ten patients a marked relief of joint pain was achieved within 28 days. Daily doses of less than 200 micrograms IFN-gamma did not have any effect on the skin lesions. Tolerance of the drug, given subcutaneously, was dose-dependent, no side-effects occurred with dosages of less than 100 micrograms/d.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0012-0472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
111
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1313-6
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:3091352-Adult,
pubmed-meshheading:3091352-Aged,
pubmed-meshheading:3091352-Arthritis,
pubmed-meshheading:3091352-Drug Tolerance,
pubmed-meshheading:3091352-Humans,
pubmed-meshheading:3091352-Interferon-gamma,
pubmed-meshheading:3091352-Middle Aged,
pubmed-meshheading:3091352-Psoriasis,
pubmed-meshheading:3091352-Time Factors
|
pubmed:year |
1986
|
pubmed:articleTitle |
[Gamma interferon in psoriatic arthritis].
|
pubmed:publicationType |
Journal Article,
English Abstract
|